References
- 1. M. Casas, C. Ferrero and M. R. Jiménez-Castellanos, Graft tapioca starch copolymers as novel excipients for controlled-release matrix tablets, Carbohydr. Polym. 80 (2010) 71-77; DOI: 10.1016/ j.carbpol.2009.10.065.
- 2. E. Costa, A. Arancibia and J. M. Aïache, Sistemas matriciales, Act. Farm. Bonaerense 23 (2004) 259-265.
- 3. I. Caraballo, M. Fernández-Arevalo, M. A. Holgado and A. M. Rabasco, Percolation theory: application to the study of the release behaviour from inert matrix systems, Int. J. Pharm. 96 (1993) 175-181; DOI: 10.1016/0378-5173(93)90225-5.
- 4. P. R. Katikaneni, S. M. Upadrashta, S. H. Neau and A. K. Mitra, Ethylcellulose matrix controlled release tablets of a water-soluble drug, Int. J. Pharm. 123 (1995) 119-125; DOI: 10.1016/0378- -5173(95)00060-V.
- 5. S. I. Pather, I. Rusell, J. A. Syce and S. H. Neau, Sustained release theophylline tablets by direct compression: Part 1: formulation and in vitro testing, Int. J. Pharm. 164 (1998) 1-10; DOI: 10.1016/ S0378-5173(97)00348-7.
- 6. S. M. Upadrashta, P. R. Katikaneni, G. A. Hileman, S. H. Neau and C. E. Rowlings, Compressibility and compactibility properties of ethylcellulose, Int. J. Pharm. 112 (1994) 173-179; DOI: 10.1016/ 0378-5173(94)90427-8.
- 7. D. Stauffer and A. Aharony, Introduction to Percolation Theory, 2nd ed., Taylor & Francis, London 1992.
- 8. I. Caraballo, Factors affecting drug release from hydroxypropyl methyl cellulose matrix systems in the light of classical and percolation theories, Expert Opin. Drug Deliv. 7 (2010) 1291-1301; DOI: 10.1517/17425247.2010.528199.
- 9. H. Leuenberger, B. D. Rohera and C. Haas, Percolation theory - a novel approach to solid dosage form design, Int. J. Pharm. 38 (1987) 109-115; DOI: 10.1016/0378-5173(87)90105-0.
- 10. D. Blattner, M. Kolb and H. Leuenberger, Percolation theory and compactability of binary powder systems, Pharm. Res. 7 (1990) 113-117; DOI: 10.1023/A:1015864415693.
- 11. J. D. Bonny and H. Leuenberger, Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics, Pharm. Acta Helv. 66 (1991) 160-164.
- 12. J. D. Bonny and H. Leuenberger, Matrix type controlled release systems II. Percolation effects in non-swellable matrices, Pharm. Acta Helv. 68 (1993) 25-33; DOI: 10.1016/0031-6865(93)90005-Q.
- 13. L. E. Holman and H. Leuenberger, The relationship between solid fraction and mechanical properties of compacts - the percolation theory model approach, Int. J Pharm. 46 (1988) 35-44; DOI: DOI: 10.1016/0378-5173(88)90007-5.
- 14. H. Leuenberger and R. Leu, Formation of a tablet: a site and bond percolation phenomenon, J. Pharm. Sci. 81 (1992) 976-982; DOI: 10.1002/jps.2600811004.
- 15. I. Caraballo, L. M. Melgoza, J. Alvarez-Fuentes, M. C. Soriano and A. M. Rabasco, Design of controlled release inert matrices of naltrexone hydrochloride based on percolation concepts, Int. J. Pharm. 181 (1999) 23-30; DOI: 10.1016/S0378-5173(98)00415-3.
- 16. L. M. Melgoza, I. Caraballo, J. Alvarez-Fuentes, M. Millan and A. M. Rabasco, Study of morphine hydrochloride percolation threshold in Eudragit® RS-PM matrices, Int. J. Pharm. 170 (1998) 169-177; DOI: 10.1016/S0378-5173(98)00135-5.
- 17. E. Castellanos-Gil, I. Caraballo and B. Bataille, Tablet Design, in Pharmaceutical Manufacturing Handbook:Production and Processes (Ed. S. C. Gad), Wiley InterScience, New Jersey 2008, pp. 977-1052.
- 18. L. M. Melgoza, A. M. Rabasco, H. Sandoval and I. Caraballo, Estimation of the percolation thresholds in dextromethorphan hydrobromide matrices, Eur. J. Pharm. Sci. 12 (2001) 453-459; DOI: 10.1016/S0928-0987(00)00193-7.
- 19. M. C. Soriano, I. Caraballo, M. Millan, R. T. Piñero, L. M. Melgoza and A. M. Rabasco, Influence of two different types of excipient on drug percolation threshold, Int. J. Pharm. 174 (1998) 63-69; DOI: 10.1016/S0378-5173(98)00255-5.
- 20. I. Caraballo, M. Fernandez-Arevalo, M. Millan, A.M.Rabasco and H. Leuenberger, Int. J. Pharm. 139 (1996) 177-186; DOI: 10.1016/0378-5173(96)04603-0.
- 21. United States Pharmacopoeia 26, National Formulary 21, USP Convention, Rockwille 2011.
- 22. T. Higuchi, Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149.
- 23. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378- -5173(83)90064-9.
- 24. N. A. Peppas and J. J. Sahlin, A simple equation for the description of solute release. III. Coupling of diffusion and relaxation, Int. J. Pharm. 57 (1989) 169-172; DOI: 10.1016/0378-5173(89)90306-2.
- 25. P. L. Ritger and N. A. Peppas, A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, J. Control. Release 5 (1987) 23-36; DOI: 10.1016/0168-3659(87)90034-4.
- 26. I. Fuertes, A. Miranda, M. Millan and I. Caraballo, Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets, Eur. J. Pharm. Biopharm. 64 (2006) 336-342; DOI: 10.1016/ j.ejpb.2006.05.009.
- 27. I. Caraballo, M. Millán and A. M. Rabasco, Relationship between drug percolation threshold and particle size in matrix tablets, Pharm. Res. 13 (1996) 387-390; DOI: 10.1023/A:1016088424993.
- 28. M. Millán, I. Caraballo and A. M. Rabasco, The role of the drug/excipient particle size ratio in the percolation model for tablets, Pharm. Res. 15 (1998) 216-220; DOI: 10.1023/A:1011906416291.
- 29. I. Caraballo, M. Millan, A. Fini, L. Rodriguez and C. Cavallari, Percolation thresholds in ultrasound compacted tablets, J. Control. Release 69 (2000) 345-355; DOI: 10.1016/S0168-3659(00)00307-2.